FAYETTEVILLE — Who will be the 22 starters when Arkansas football opens the 2026 season against North Alabama? It's way-too-early to know, but that doesn't make the exercise of guessing any less ...

A Clark County mother has filed a lawsuit against Kaiser Permanente Northwest and six of its physicians that alleges they failed to warn her daughter of the potential risk of brain tumors associated ...

-- Global pharmaceutical company Pfizer Inc. (NYSE: PFE), manufacturer of contraceptive injection Depo-Provera (DMPA), is facing a Multidistrict Litigation (MDL No. 3140) in the USA being brought on ...

PENSACOLA, Fla.--(BUSINESS WIRE)--At a Case Management Conference in the Multi District Litigation against Pfizer Inc. (NYSE:PFE), the Honorable M. Casey Rodgers set a date for the first Trial, which ...

At a Case Management Conference in the Multi District Litigation against Pfizer Inc. (NYSE:PFE), the Honorable M. Casey Rodgers set a date for the first Trial, which will take place in December 2026, ...

The U.S. Food and Drug Administration (FDA) has approved a major safety update to the label of Depo-Provera, a widely used birth control injection. Nearly 2,000 women have filed lawsuits against ...

Judge in Depo-Provera MDL Orders Additional Briefing on FDA's Brain Tumor Warning At a Friday hearing, U.S. District Judge M. Casey Rodgers, of the Northern District of Florida, ordered supplemental ...

The decision comes as Pfizer faces lawsuits from more than 1000 women who say the company knew about the risks and didn’t warn them. The agency signed off last week on a label update for 2 versions of ...

Add Yahoo as a preferred source to see more of our stories on Google. The FDA has approved a label change to Pfizer's contraceptive injection The US Food and Drug Administration (FDA) has approved a ...

CLEVELAND — The Food and Drug Administration has approved a new warning label for Depo-Provera, one of the most widely used birth control shots in the United States, alerting users to a potential risk ...

U.S. government regulators have approved a new brain tumor warning for Depo-Provera Lawsuits from more than 1,000 women claim they weren’t warned sooner Regulators in Europe and Canada previously ...

The FDA has approved a label change on the long-acting injectable contraceptive depot medroxyprogesterone acetate, commonly known as Depo-Provera, to warn users of a potential risk of meningioma. The ...